Age: We compare the young, middle-aged, and old groups
Parkinson's disease (PD): We compare the healthy group and PD group.
Study summary
Both aging and Parkinson's disease (PD) negatively affect postural control and increase the risk of falls, with frontal plane balance being particularly challenging for these populations. While previous studies have mainly focused on sagittal plane balance, the contribution of hip abductor muscles remains unclear, especially regarding their force production and control abilities. Therefore, this study aims to investigate hip abductor muscle force production and force control, and to examine whether these factors are associated with postural control, gait, and balance performance in individuals across different ages and those with PD.
Eligibility
Sex
ALL
Min age
20 Years
Max age
85 Years
Healthy volunteers
Accepted
Healthy people
Inclusion Criteria:
* 20 to 39 years (young), 40 to 59 years (young), and 60-85 years (old)
* generally in good health
* able to walk 10 m independently
* able to follow all instructions
Exclusion Criteria:
* neurologic, psychiatric, immune, integumentary, and musculoskeletal diseases or disorders which might influence this study
* any pain over the lower extremities
* uncontrolled cardiovascular diseases
* unable to provide informed consent.
PD
Inclusion Criteria:
* clinical diagnosis of idiopathic PD
* Hoehn and Yahr stages 1 to 3
* stable anti-PD medications
* able to walk 10 m independently
* able to follow all instructions
Exclusion Criteria:
* psychiatric, immune, integumentary, and musculoskeletal diseases or disorders which might influence this study
* neurological conditions other than PD
* any pain over the lower extremities
* uncontrolled cardiovascular diseases
* unable to provide informed consent.
Primary outcome measure(s)
Maximal force — Baseline The maximal force of lower extremity muscles
Rate of torque development — Baseline The ability to rapidly generate muscle force
Force steadiness — Baseline The ability to maintain a constant force output during a submaximal contraction
Walking speed — Baseline The time taken by participants to walk a standardized distance
Step Length — Baseline The linear distance between the two ankles, typically expressed in centimeter(cm).
Cadence — Baseline The number of steps taken per minute (SPM)
Single Support Time — Baseline The duration within the gait cycle when only one foot is in contact with the ground, typically measured in seconds or as a percentage of the total gait cycle.
Double Support Time — Baseline The portion of the gait cycle where both feet are in contact with the ground, indicating the transition phase between steps, expressed as a percentage of the gait cycle or in seconds.
Swing Time — Baseline The portion of the gait cycle where the foot is not in contact with the ground, moving forward to the next step. It is usually expressed as a percentage of the total gait cycle or in seconds.
Center of Pressure (COP) Velocity in Balance Tasks — Baseline The speed at which the COP moves, calculated over the duration of the balance task. Higher velocities may reflect more dynamic balance adjustments or instability. Unit:millimeter per second(mm/s)
Center of Pressure (COP) Area in Balance Tasks — Baseline The area covered by the COP trajectory during the balance task, providing an estimate of the sway envelope. A larger area might indicate poorer balance control. Unit:square millimeter(mm\^2)
Timed Up-and-Go Test — Baseline Tthe time an individual takes to stand up from a chair, walk 3 meters, turn around, walk back, and sit down.
Four Square Step Test — Baseline Participants will be required to perform four square step test by changing directions while stepping forward, sideway, and backward over a low obstacle as fast as possible.
Trial sites (2)
Facility
City
Region
Status
Chang Gung Memorial Hospital
Taoyuan
Taiwan
Recruiting
Chang Gung University
Taoyuan
Taiwan
Recruiting
More Chang Gung Memorial Hospital trials in Taiwan
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.